ID

12471

Descripción

The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI). https://clinicaltrials.gov/ct2/show/NCT01294462

Link

https://clinicaltrials.gov/ct2/show/NCT01294462

Palabras clave

Versiones (2)
  1. 28/7/15 28/7/15 -
  2. 21/11/15 21/11/15 -
Subido en

21 de noviembre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Ticagrelor Versus Clopidogrel Acute Coronary Syndrome NCT01294462

Inglés

Eligibility criteria

1 formularios  
  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion Criteria
Descripción

Inclusion Criteria

Provision of signed informed consent
Descripción

Provision of signed informed consent

Tipo de datos

boolean

Alias
UMLS CUI-1
C0021430
Index event of ST segment elevation ACS
Descripción

Index event of non-ST or ST segment elevation ACS

Tipo de datos

boolean

Alias
UMLS CUI-1
C1536220
Index event of non-ST segment elevation ACS
Descripción

Index event of non-ST segment elevation ACS

Tipo de datos

boolean

Alias
UMLS CUI-1
C3537184
Exclusion criteria
Descripción

Exclusion criteria

Index event is an acute complication of percutaneous coronary intervention
Descripción

Index event is an acute complication of percutaneous coronary intervention

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C1532338
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
Descripción

Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment

Tipo de datos

boolean

Alias
UMLS CUI-1
C1532338
Oral anticoagulation therapy that cannot be stopped
Descripción

Oral anticoagulation therapy that cannot be stopped

Tipo de datos

boolean

Alias
UMLS CUI-1
C0003281
The conditions associated with increased risk of bradycardiac events
Descripción

The conditions associated with increased risk of bradycardiac events

Tipo de datos

boolean

Alias
UMLS CUI-1
C0428977
Volver a la parte superior de la página

Similar models

Eligibility criteria

1 formularios
  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion Criteria
Informed consent
Item
Provision of signed informed consent
boolean
C0021430 (UMLS CUI-1)
STEMI
Item
Index event of ST segment elevation ACS
boolean
C1536220 (UMLS CUI-1)
NSTEMI
Item
Index event of non-ST segment elevation ACS
boolean
C3537184 (UMLS CUI-1)
Item Group
Exclusion criteria
PCI complication
Item
Index event is an acute complication of percutaneous coronary intervention
boolean
C0009566 (UMLS CUI [1,1])
C1532338 (UMLS CUI [1,2])
PCI
Item
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
boolean
C1532338 (UMLS CUI-1)
anticoagulation therapy
Item
Oral anticoagulation therapy that cannot be stopped
boolean
C0003281 (UMLS CUI-1)
Bradycardia
Item
The conditions associated with increased risk of bradycardiac events
boolean
C0428977 (UMLS CUI-1)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial